| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 126 |
| 1 | PREDNISONE | 71 |
| 2 | ADALIMUMAB | 56 |
| 3 | ERGOCALCIFEROL | 33 |
| 4 | OMALIZUMAB | 31 |
| 5 | METHOTREXATE SODIUM | 30 |
| 6 | VEDOLIZUMAB | 30 |
| 7 | METHOTREXATE | 28 |
| 8 | INFLIXIMAB | 26 |
| 9 | ALBUTEROL SULFATE | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLABENDAZOLE | 2 | 0.0455 |
| 1 | DEXTROMETHORPHAN HBR 20MG GUAIFENESIN 400MG | 1 | 0.0164 |
| 2 | GUAIFENESIN, DEXTROMETHORPHAN HBR | 1 | 0.0152 |
| 3 | FERRIC OXIDE RED, ZINC OXIDE, AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0152 |
| 4 | DEXTROMETHORPHAN HBR AND GUAIFENESIN | 1 | 0.0133 |
| 5 | PECTIN | 1 | 0.0125 |
| 6 | GUAIFENESIN AND DEXTROMETHORPHAN HBR | 1 | 0.0105 |
| 7 | NITAZOXANIDE | 2 | 0.0057 |
| 8 | ALBENDAZOLE | 10 | 0.0053 |
| 9 | MEBENDAZOLE | 4 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 129 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 126 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 65 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 4 | Integrin Receptor Antagonist [EPC] | 41 |
| 5 | Provitamin D2 Compound [EPC] | 33 |
| 6 | Anti-IgE [EPC] | 31 |
| 7 | Benzodiazepine [EPC] | 30 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 29 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 12 | 0.0174 |
| 1 | Anthelmintic [EPC] | 17 | 0.0058 |
| 2 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 3 | Antiparasitic [EPC] | 18 | 0.0040 |
| 4 | Pediculicide [EPC] | 18 | 0.0038 |
| 5 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 6 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 7 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 8 | Pyrethroid [EPC] | 2 | 0.0011 |
| 9 | Provitamin D2 Compound [EPC] | 33 | 0.0011 |